GW Pharmaceuticals
E874301
GW Pharmaceuticals is a biopharmaceutical company known for pioneering cannabis-based prescription medicines, including the epilepsy treatment Epidiolex.
All labels observed (1)
| Label | Occurrences |
|---|---|
| GW Pharmaceuticals canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T10609878 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: GW Pharmaceuticals Context triple: [Epidiolex, developedBy, GW Pharmaceuticals]
-
A.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
B.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
-
C.
Central Coast Pharmaceuticals
Central Coast Pharmaceuticals is a fictional pharmaceutical sales company featured in the TV series "Psych," where Burton "Gus" Guster works as a pharmaceutical sales representative.
-
D.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company best known for developing transformative therapies for cystic fibrosis and other serious diseases using a precision medicine approach.
-
E.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: GW Pharmaceuticals Target entity description: GW Pharmaceuticals is a biopharmaceutical company known for pioneering cannabis-based prescription medicines, including the epilepsy treatment Epidiolex.
-
A.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
B.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
-
C.
Central Coast Pharmaceuticals
Central Coast Pharmaceuticals is a fictional pharmaceutical sales company featured in the TV series "Psych," where Burton "Gus" Guster works as a pharmaceutical sales representative.
-
D.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company best known for developing transformative therapies for cystic fibrosis and other serious diseases using a precision medicine approach.
-
E.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
public company ⓘ |
| acquiredBy | Jazz Pharmaceuticals NERFINISHED ⓘ |
| acquisitionDate | 2021-05-05 ⓘ |
| acquisitionValue | 7200000000 USD ⓘ |
| country | United Kingdom ⓘ |
| delistedFrom |
London Stock Exchange
NERFINISHED
ⓘ
NASDAQ NERFINISHED ⓘ |
| develops | cannabinoid-based prescription medicines ⓘ |
| EpidiolexActiveIngredient | cannabidiol ⓘ |
| EpidiolexFormulation | oral solution ⓘ |
| EpidiolexIndication |
Dravet syndrome
NERFINISHED
ⓘ
Lennox-Gastaut syndrome NERFINISHED ⓘ tuberous sclerosis complex ⓘ |
| focusesOn |
multiple sclerosis symptom management
ⓘ
rare and severe forms of epilepsy ⓘ |
| formerHeadquartersLocation | Porton Down, Wiltshire, United Kingdom NERFINISHED ⓘ |
| foundedBy |
Brian Whittle
NERFINISHED
ⓘ
Geoffrey Guy NERFINISHED ⓘ |
| hasSubsidiary | GW Research Ltd NERFINISHED ⓘ |
| headquartersLocation | Cambridge, United Kingdom NERFINISHED ⓘ |
| inception | 1998 ⓘ |
| industry |
biotechnology industry
ⓘ
pharmaceutical industry ⓘ |
| legalForm | public limited company ⓘ |
| listedOn | London Stock Exchange NERFINISHED ⓘ |
| locatedInTimeZone | Europe/London ⓘ |
| notableFor | first FDA-approved plant-derived cannabinoid medicine ⓘ |
| notableProduct |
Epidiolex
NERFINISHED
ⓘ
Sativex NERFINISHED ⓘ |
| parentOrganization | Jazz Pharmaceuticals NERFINISHED ⓘ |
| partOf | cannabis industry ⓘ |
| regulatoryApproval |
Epidiolex EMA approval 2019
ⓘ
Epidiolex FDA approval 2018 ⓘ Sativex approvals in multiple countries ⓘ |
| regulatoryBodyInteraction |
European Medicines Agency
NERFINISHED
ⓘ
U.S. Food and Drug Administration NERFINISHED ⓘ |
| researchArea |
cannabinoid science
ⓘ
central nervous system disorders ⓘ |
| SativexActiveIngredients |
cannabidiol
ⓘ
tetrahydrocannabinol ⓘ |
| SativexFormulation | oromucosal spray ⓘ |
| SativexIndication | multiple sclerosis spasticity ⓘ |
| specializesIn |
cannabis-based medicines
ⓘ
epilepsy treatments ⓘ neurology ⓘ |
| stockExchange | NASDAQ ⓘ |
| tickerSymbol | GWPH NERFINISHED ⓘ |
| website | https://www.gwpharm.com/ ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: GW Pharmaceuticals Description of subject: GW Pharmaceuticals is a biopharmaceutical company known for pioneering cannabis-based prescription medicines, including the epilepsy treatment Epidiolex.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.